# Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

> **NCT00214942** · PHASE3 · COMPLETED · sponsor: **Cephalon**

## Conditions studied

- Chronic Low Back Pain

## Interventions

- **DRUG:** ORAVESCENT Fentanyl Citrate

## Key facts

- **NCT ID:** NCT00214942
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-03
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214942, "Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00214942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*